United Kingdom: A new approach to patent infringement

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

United Kingdom: A new approach to patent infringement

In a landmark decision on patent infringement (Actavis UK Limited v Eli Lilly & Company [2017] UKSC 48), the Supreme Court has confirmed that UK law does provide for a doctrine of equivalents when determining the scope of patent protection.

Prior to this decision, determining the issue of infringement in the UK required a "purposive" construction of the patent claims. In any purposive construction, the courts would establish the meaning of the claim language in the eyes of the skilled person, before deciding whether any alleged infringement fell within the scope of this meaning. If an alleged infringement was outside of this scope, there would be no infringement.

In other words, the language of the patent was considered to be of critical importance and, if the language of a claim could not be construed to extend to an equivalent, this equivalent did not represent an infringement. However, in the approach established by this recent decision, infringement may now arise even when the specific language of a claim would not be understood as extending to the alleged equivalent.

The Supreme Court judgment helpfully sets out guidance for determining whether there is infringement in such circumstances. In simple terms, for an equivalent to represent an infringement, the equivalent must obviously achieve the same result in the same way as the invention in the eyes of the skilled person when viewed at the priority date. Additionally, the skilled person must conclude there was no requirement for strict compliance with the literal meaning of the relevant claims. If these conditions are satisfied, the equivalent will represent an infringement.

While this most recent decision in July 2017 represents a new approach for the UK courts, this refreshed approach to equivalents is closely aligned with that taken by the German and Dutch courts. Accordingly, this decision can certainly be viewed as an attempt to align the interpretation of infringement across Europe before the first cases at the new Unified Patent Court.

Chapman

Helga Chapman

Chapman + Co

Kings Park House, 22 Kings Park Road

Southampton SO15 2AT

United Kingdom

Tel: +44 (0) 23 80000 2022

info@chapmanip.com  

www.chapmanip.com

more from across site and SHARED ros bottom lb

More from across our site

The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Leaders at IP boutique say the decision to pursue sponsorless partnership with the specialised investment arm of a private equity firm comes at a time of ‘profound transformation’ in the profession
Gift this article